Universitätsklinikum Göttingen

Hospital


Location: Göttingen, Germany (DE) DE

ISNI: 0000000104825331

ROR: https://ror.org/021ft0n22

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies Forty Molecularly Homogenous and Histologically Variable Cases With Favorable Outcome (2021) Gloss S, Jurmeister P, Thieme A, Schmid S, Cai WY, Serrette RN, Perner S, et al. Journal article Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma (2021) Straka C, Salwender H, Knop S, Vogel M, Muller J, Metzner B, Langer C, et al. Journal article CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma (2021) Klümper N, Ralser DJ, Zarbl R, Schlack K, Schrader AJ, Rehlinghaus M, Hoffmann MJ, et al. Journal article Risk-Adjusted Cancer Screening and Prevention (RiskAP): complementing screening for early disease detection by a learning screening based on risk factor (2021) Schmutzler RK, Schmitz-Luhn B, Borisch B, Devilee P, Eccles D, Hall P, Balmaña J, et al. Journal article, Original article TNT in rectal cancer: Final results of the CAO/ARO/AIO-12 randomized phase 2 trial (2021) Fokas E, Schlenska-Lange A, Polat B, Klautke G, Fietkau R, Kuhnt T, Brunner T, et al. Conference contribution Primary renal sarcomas: imaging features and discrimination from non-sarcoma renal tumors (2021) Uhlig J, Uhlig A, Bachanek S, Onur MR, Kinner S, Geisel D, Kohler M, et al. Journal article SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination (2021) Hoffmann M, Hofmann-Winkler H, Krüger N, Kempf A, Nehlmeier I, Graichen L, Arora P, et al. Journal article Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas (2021) Liebers N, Duell J, Fitzgerald D, Kerkhoff A, Noerenberg D, Kaebisch E, Acker F, et al. Journal article Neurocognitive outcomes in pediatric patients following brain irradiation (2021) Weusthof K, Luttich P, Regnery S, Konig L, Bernhardt D, Witt O, Herfarth K, et al. Journal article Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis (2021) Koch E, Petzold A, Wessely A, Dippel E, Gesierich A, Gutzmer R, Hassel JC, et al. Journal article